Pyruvate decarboxylase, the target for omeprazole in metronidazole-resistant and iron-restricted Tritrichomonas foetus

. 2004 Jun ; 48 (6) : 2185-9.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid15155220

The substituted benzimidazole omeprazole, used for the treatment of human peptic ulcer disease, inhibits the growth of the metronidazole-resistant bovine pathogen Tritrichomonas foetus in vitro (MIC at which the growth of parasite cultures is inhibited by 50%, 22 microg/ml [63 microM]). The antitrichomonad activity appears to be due to the inhibition of pyruvate decarboxylase (PDC), which is the key enzyme responsible for ethanol production and which is strongly upregulated in metronidazole-resistant trichomonads. PDC was purified to homogeneity from the cytosol of metronidazole-resistant strain. The tetrameric enzyme of 60-kDa subunits is inhibited by omeprazole (50% inhibitory concentration, 16 microg/ml). Metronidazole-susceptible T. foetus, which expresses very little PDC, is only slightly affected. Omeprazole has the same inhibitory effect on T. foetus cells grown under iron-limited conditions. Similarly to metronidazole-resistant cells, T. foetus cells grown under iron-limited conditions have nonfunctional hydrogenosomal metabolism and rely on cytosolic PDC-mediated ethanol fermentation.

Zobrazit více v PubMed

Belli, W. A., and J. Fryklund. 1995. Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori by using permeabilized cells. Antimicrob. Agents Chemother. 39:1717-1720. PubMed PMC

Čerkasovová, A., J. Čerkasov, and J. Kulda. 1984. Metabolic differences between metronidazole resistant and susceptible strains of Tritrichomonas foetus. Mol. Biochem. Parasitol. 11:105-118. PubMed

Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, B. G. Barrell, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544. PubMed

Cole, S. T., K. Eiglmeier, J. Parkhill, K. D. James, N. R. Thomson, P. R. Wheeler, N. Honore, T. Garnier, C. Churcher, D. Harris, K. Mungall, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. M. Davies, K. Devlin, S. Duthoy, T. Feltwell, A. Fraser, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, C. Lacroix, J. Maclean, S. Moule, L. Murphy, K. Oliver, M. A. Quail, M. A. Rajandream, K. M. Rutherford, S. Rutter, K. Seeger, S. Simon, M. Simmonds, J. Skelton, R. Squares, S. Squares, K. Stevens, K. Taylor, S. Whitehead, J. R. Woodward, and B. G. Barrell. 2001. Massive gene decay in the leprosy bacillus. Nature 409:1007-1011. PubMed

Diamond, L. S. 1957. The establishment of various trichomonads of animals and man in axenic cultures. J. Parasitol. 43:488-490. PubMed

Edwards, D. I. 1993. Nitroimidazole drugs—action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31:9-20. PubMed

Fellenius, E., T. Berglindh, G. Sachs, L. Olbe, B. Elander, S. E. Sjostrand, and B. Wallmark. 1981. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+, K+)ATPase. Nature 290:159-161. PubMed

Holzer, H., G. Schultz, C. Villar-Palasi, and J. Jüntgen-Sell. 1956. Isolierung der Hefepyruvatdecarboxylase und Untersuchungen über Aktivität des Enzyms in lebenden Zellen. Biochem. Z. 327:331-334. PubMed

Iwahi, T., H. Satoh, M. Nakao, T. Iwasaki, T. Yamazaki, K. Kubo, T. Tamura, and A. Imada. 1991. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob. Agents Chemother. 35:490-496. PubMed PMC

Jiang, S., J. Meadows, S. A. Anderson, and A. J. Mukkada. 2002. Antileishmanial activity of the antiulcer agent omeprazole. Antimicrob. Agents Chemother. 46:2569-2574. PubMed PMC

Kaiser, B., T. Munder, H. P. Saluz, W. Kunkel, and R. Eck. 1999. Identification of a gene encoding the pyruvate decarboxylase gene regulator CaPdc2p from Candida albicans. Yeast 15:585-591. PubMed

Konig, S. 1998. Subunit structure, function and organisation of pyruvate decarboxylases from various organisms. Biochim. Biophys. Acta 1385:271-286. PubMed

Korting, W., and D. Fairbairn. 1972. Anaerobic energy metabolism in Moniliformis dubius (Acanthocephala). J. Parasitol. 58:45-50. PubMed

Kulda, J., J. Čerkasov, P. Demeš, and A. Čerkasovová. 1984. Tritrichomonas foetus: stable anaerobic resistance to metronidazole in vitro. Exp. Parasitol. 57:93-103. PubMed

Kulda, J., H. Kabíčková, J. Tachezy, A. Čerkasovová, and J. Čerkasov. 1988. Metronidazole resistant trichomonads: mechanism of in vitro developed anaerobic resistance, p. 137-160. In D. Lloyd, G. H. Coombs, and T. A. Paget (ed.), Biochemistry and molecular biology of anaerobic protozoa. Harwood Academic, Chur, Switzerland.

Kulda, J. 1999. Trichomonads, hydrogenosomes and drug resistance. Int. J. Parasitol. 29:199-212. PubMed

Lorentzon, P., R. Jackson, B. Wallmark, and G. Sachs. 1987. Inhibition of (H+, K+) ATPase by omeprazole in isolated gastric vesicles requires proton transport. Biochim. Biophys. Acta 897:41-51. PubMed

Müller, M. 1981. Action of clinically utilized 5-nitroimidazoles on microorganisms. Scand. J. Infect. Dis. Suppl. 26:31-41. PubMed

Nixon, P. F., R. J. Diefenbach, and R. G. Duggleby. 1992. Inhibition of transketolase and pyruvate decarboxylase by omeprazole. Biochem. Pharmacol. 44:177-179. PubMed

Raj, K. C., L. A. Talarico, L. O. Ingram, and J. A. Maupin-Furlow. 2002. Cloning and characterization of the Zymobacter palmae pyruvate decarboxylase gene (pdc) and comparison to bacterial homologues. Appl. Environ. Microbiol. 68:2869-2876. PubMed PMC

Rivoal, J., B. Ricard, and A. Pradet. 1990. Purification and partial characterization of pyruvate decarboxylase from Oryza sativa L. Eur. J. Biochem. 194:791-797. PubMed

Sasaki, Y., J. Ishikawa, A. Yamashita, K. Oshima, T. Kenri, K. Furuya, C. Yoshino, A. Horino, T. Shiba, T. Sasaki, and M. Hattori. 2002. The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans. Nucleic Acids Res. 30:5293-5300. PubMed PMC

Tachezy, J., J. Kulda, I. Bahníková, P. Suchan, J. Rázga, and J. Schrével. 1996. Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin. Exp. Parasitol. 83:216-228. PubMed

Tachezy, J., P. Suchan, J. Schrével, and J. Kulda. 1998. The host-protein-independent iron uptake by Tritrichomonas foetus. Exp. Parasitol. 90:155-163. PubMed

Vañáčová, S., D. Rasoloson, J. Rázga, I. Hrdý, J. Kulda, and J. Tachezy. 2001. Iron-induced changes in pyruvate metabolism of Tritrichomonas foetus and involvement of iron in expression of hydrogenosomal proteins. Microbiology 147:53-62. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...